Incheon Labor Commission Dismisses Samsung Biologics Union’s Unfair Labor Practice Application

The unfair labor practice remedy application filed by the Samsung Biologics labor union, which claimed that the management suppressed legitimate union activities ahead of a planned strike, has been dismissed.

Samsung Biologics Yonhap News

On July 13, the Incheon Regional Labor Relations Commission announced that it had dismissed the unfair labor practice remedy application submitted by the Samsung Biologics Coexistence Union against the management.

Previously, in May, the Samsung Biologics labor union filed for relief, claiming that an email and online post from the CEO—stating that a strike could affect credibility and bonuses—constituted an unfair labor practice intended to discourage union activities ahead of a planned strike.

The Incheon Regional Labor Relations Commission is known to have accepted the management's argument that informing employees about the potential impact on production due to a strike was a necessary business activity.

An official from the Incheon Regional Labor Relations Commission stated, "The written decision has not yet been completed, so we cannot disclose the specific reasons for the dismissal," and added, "It usually takes about one month to notify the decision in writing."

The union plans to file an appeal with the Central Labor Relations Commission as soon as it receives the written decision.

Previously, the union submitted a total of four complaints to the labor authorities, including two cases of unfair labor practices—one of which is the current issue—and two cases of violations of the Labor Standards Act. The remaining cases are reportedly still under investigation.

This content was produced with the assistance of AI translation services.